Combipatch

   
Google
 
Web NewDrugInformation.com

Combipatch


Drug - Combipatch
The trade name of the product as shown on the labeling.

Dosage - FILM, EXTENDED RELEASE; TRANSDERMAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Estradiol; Norethindrone Acetate
Multiple ingredients are in alphabetical order.

Strength - 0.05MG/24HR;0.14MG/24HR
The potency of the active ingredient(s), Estradiol; Norethindrone Acetate. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Combipatch. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020870
The FDA assigned number to Combipatch. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Combipatch. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 7, 1998
The date Combipatch was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Combipatch. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Combipatch is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Combipatch.

Combipatch